SBMLX
Price
$24.04
Change
-$0.11 (-0.46%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

SBMLX vs VIMSX

Header iconSBMLX vs VIMSX Comparison
Open Charts SBMLX vs VIMSXBanner chart's image
ClearBridge Mid Cap C
Price$24.04
Change-$0.11 (-0.46%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SBMLX vs VIMSX Comparison Chart
Loading...
VS
SBMLX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBMLX is a Buy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. SBMLX (1.79B). VIMSX pays higher dividends than SBMLX: VIMSX (1.38) vs SBMLX (0.00). SBMLX was incepted earlier than VIMSX: SBMLX (26 years) vs VIMSX (26 years). SBMLX is a more actively managed with annual turnover of: 38.00 vs. VIMSX (13.00). SBMLX has a lower initial minimum investment than VIMSX: SBMLX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 25.11 vs. SBMLX (12.28). VIMSX return over 5 years is better than : 56.75 vs. SBMLX (-11.91).
SBMLXVIMSXSBMLX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years26 years-
Gain YTD6.27812.55750%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B172B1%
Annual Yield % from dividends0.001.38-
Returns for 1 year12.2825.1149%
Returns for 3 years-25.859.82-263%
Returns for 5 years-11.9156.75-21%
Returns for 10 years-4.83128.21-4%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma